Natalie Teh specialises in liquid biopsy, nanotechnology diagnostic, extracellular vesicles and immunology for neurodegenerative diseases.
Natalie Teh started her research in creating novel nanocarriers by fusing the extracellular vesicle with synthetic nanoparticles such as liposomes and lipid nanoparticles to create the next generation of mRNA drug delivery systems. This research was designed to deliver anti-aging therapy for diabetic kidney disease to address the aging population. Subsequently, she was awarded the Earmark Scholarship to pursue her PhD with the Wuethrich Group. Her PhD project entails profiling motor neuron diseases such as Amyotrophic Lateral Sclerosis for signature biomarkers to enable disease prognosis and personalised treatment for this incurable disease through hijacking and decoding the extracellular vesicle communication system using an advanced nanotechnology platform such as the Surface-Enhanced Raman Scattering nanopillar.
Industry
She has over 10 years of working experience in Quality Management Systems and method validations for microbiology tests with multinational companies in the medical device and food processing and packaging sectors.
Collaborations
Her PhD project involves collaboration with Associate Professor Shyuan Ngo who is working on neurodegenerative diseases, including MND, as well as with Trau's group for the nanotechnology platform development.
Funding
The PhD project is funded by the Motor Neurone Disease Research Institute of Australia Inc.